Advanced Research Experts PLLC — research payments reported

By program year

3 rows

Year	Kind	Amount	Payments
2025	Research	$214,947	10
2024	Research	$3,855	15
2023	Research	$14,867	17

Breakdown

Who paid Research payments · program years 2023–2025

Eli Lilly and Company $162,891 2 payments
Janssen Research & Development, LLC $50,470 6 payments
LEO Pharma AS $20,308 34 payments

Studies the money was for Research payments · program years 2023–2025

A Phase 2B, Double-Blind, Placebo-Controlled Study to Evaluate Eltrekibart in Adult Participants With Moderate to Severe Hidradenitis Suppurativa $154,681 1 payment
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled and Ustekinumab Active Comparator-controlled Study to Evaluate the Efficacy and Safety of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis $50,470 6 payments
Trace Study: Tralokinumab Real World Clinical Use: An Observational Cohort Study of Atopic Dermatitis Patients Prescribed Tralokinumab $20,308 34 payments
Observation Priority E Short - Lebrikizumab - Atopic Dermatitis $8,210 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.